Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.

BACKGROUND: Reversible cerebral vasoconstriction syndrome (RCVS) could be complicated by cerebral ischemic events. Hypothetical mechanisms of RCVS involve endothelial dysfunction and sympathetic overactivity, both of which were reported to be related to brain-derived neurotrophic factor (BDNF). The...

Full description

Bibliographic Details
Main Authors: Shih-Pin Chen, Jong-Ling Fuh, Shuu-Jiun Wang, Shih-Jen Tsai, Chen-Jee Hong, Albert C Yang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3060928?pdf=render
id doaj-c3a14f08b0e342d28be2998944689d6f
record_format Article
spelling doaj-c3a14f08b0e342d28be2998944689d6f2020-11-25T02:42:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0163e1802410.1371/journal.pone.0018024Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.Shih-Pin ChenJong-Ling FuhShuu-Jiun WangShih-Jen TsaiChen-Jee HongAlbert C YangBACKGROUND: Reversible cerebral vasoconstriction syndrome (RCVS) could be complicated by cerebral ischemic events. Hypothetical mechanisms of RCVS involve endothelial dysfunction and sympathetic overactivity, both of which were reported to be related to brain-derived neurotrophic factor (BDNF). The study investigated the association between functional BDNF Val66Met polymorphism and RCVS. METHODS: Patients with RCVS and controls were prospectively recruited and genotyped for the BDNF Val66Met polymorphism. Magnetic resonance angiography (MRA) and transcranial color-coded Doppler sonography were employed to evaluate cerebral vasoconstriction. Genotyping results, clinical parameters, vasoconstriction scores, mean flow velocities of the middle cerebral artery (V(MCA)), and Lindegaard indices were analyzed. Split-sample approach was employed to internally validate the data. PRINCIPAL FINDINGS: Ninety Taiwanese patients with RCVS and 180 age- and gender-matched normal controls of the same ethnicity completed the study. The genotype frequencies did not differ between patients and controls. Compared to patients with Met/Met homozygosity, patients with Val allele had higher mean vasoconstriction scores of all arterial segments (1.60±0.72 vs. 0.87±0.39, p<0.001), V(MCA) values (116.7±36.2 vs. 82.7±17.9 cm/s, p<0.001), and LI (2.41±0.91 vs. 1.89±0.41, p = 0.001). None of the Met/Met homozygotes, but 38.9% of the Val carriers, had V(MCA) values of >120 cm/s (p<0.001). Split-sample validation by randomization, age, entry time or residence of patients demonstrated concordant findings. CONCLUSIONS: Our findings link BDNF Val66Met polymorphism with the severity of RCVS for the first time and implicate possible pathogenic mechanisms for vasoconstriction in RCVS.http://europepmc.org/articles/PMC3060928?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Shih-Pin Chen
Jong-Ling Fuh
Shuu-Jiun Wang
Shih-Jen Tsai
Chen-Jee Hong
Albert C Yang
spellingShingle Shih-Pin Chen
Jong-Ling Fuh
Shuu-Jiun Wang
Shih-Jen Tsai
Chen-Jee Hong
Albert C Yang
Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
PLoS ONE
author_facet Shih-Pin Chen
Jong-Ling Fuh
Shuu-Jiun Wang
Shih-Jen Tsai
Chen-Jee Hong
Albert C Yang
author_sort Shih-Pin Chen
title Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
title_short Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
title_full Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
title_fullStr Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
title_full_unstemmed Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.
title_sort brain-derived neurotrophic factor gene val66met polymorphism modulates reversible cerebral vasoconstriction syndromes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description BACKGROUND: Reversible cerebral vasoconstriction syndrome (RCVS) could be complicated by cerebral ischemic events. Hypothetical mechanisms of RCVS involve endothelial dysfunction and sympathetic overactivity, both of which were reported to be related to brain-derived neurotrophic factor (BDNF). The study investigated the association between functional BDNF Val66Met polymorphism and RCVS. METHODS: Patients with RCVS and controls were prospectively recruited and genotyped for the BDNF Val66Met polymorphism. Magnetic resonance angiography (MRA) and transcranial color-coded Doppler sonography were employed to evaluate cerebral vasoconstriction. Genotyping results, clinical parameters, vasoconstriction scores, mean flow velocities of the middle cerebral artery (V(MCA)), and Lindegaard indices were analyzed. Split-sample approach was employed to internally validate the data. PRINCIPAL FINDINGS: Ninety Taiwanese patients with RCVS and 180 age- and gender-matched normal controls of the same ethnicity completed the study. The genotype frequencies did not differ between patients and controls. Compared to patients with Met/Met homozygosity, patients with Val allele had higher mean vasoconstriction scores of all arterial segments (1.60±0.72 vs. 0.87±0.39, p<0.001), V(MCA) values (116.7±36.2 vs. 82.7±17.9 cm/s, p<0.001), and LI (2.41±0.91 vs. 1.89±0.41, p = 0.001). None of the Met/Met homozygotes, but 38.9% of the Val carriers, had V(MCA) values of >120 cm/s (p<0.001). Split-sample validation by randomization, age, entry time or residence of patients demonstrated concordant findings. CONCLUSIONS: Our findings link BDNF Val66Met polymorphism with the severity of RCVS for the first time and implicate possible pathogenic mechanisms for vasoconstriction in RCVS.
url http://europepmc.org/articles/PMC3060928?pdf=render
work_keys_str_mv AT shihpinchen brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
AT jonglingfuh brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
AT shuujiunwang brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
AT shihjentsai brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
AT chenjeehong brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
AT albertcyang brainderivedneurotrophicfactorgeneval66metpolymorphismmodulatesreversiblecerebralvasoconstrictionsyndromes
_version_ 1724771800001282048